Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 12 min ago
PreprintAll rights reservedmedRxiv

Defining ocular Chlamydia trachomatis infection prevalence thresholds for the trachoma elimination endgame

32 more authors
  1. 1Department of Biology, University of Oxford, UK

Related

  1. Barriers and Factors Associated With Disclosure of Chlamydia trachomatis Infection Among Sexually Active Individuals in Buea, Cameroon: A Cross‐Sectional Study
    Pride Tanyi Bobga, Njouendou Abdel Jelil, Dickson Shey Nsagha +6
    Health science reportsPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Impact of two rounds of azithromycin mass drug administration on active trachoma and ocular Chlamydia trachomatis infection in Naoero
    Carleigh S. Cowling, Sue-Chen Apadinuwe, Anasaini Cama +10
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BY 4.0Full textImmunologyEpidemiology & public healthPLOS
  3. Less is more: reconsidering asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae screening for gay, bisexual and other men who have sex with men in the era of doxycycline post-exposure prophylaxis (DoxyPEP)
    David James Field, Johnny Boylan, Fiona Lyons +2
    International Journal of STD & AIDSPeer-reviewedCC BY 4.0Full textInfectious diseasePMC
  4. Interlaboratory comparison of a multiplex bead assay against the Chlamydia trachomatis antigen Pgp3 using two monoclonal antibody clones
    Sarah Gwyn, Karana Wickens, Helena Brazal Monzo +9
    PLOS Global Public HealthPeer-reviewedCC0Full textMolecular biology & gene regulationImmunologyPLOSPMC
  5. Chlamydia trachomatis and Neisseria gonorrhoeae in newborns with and without neonatal conjunctivitis: cross-sectional study in Papua New Guinea
    N. Low, A. Mengi, L. M. Vallely +11
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
BibTeX
@misc{borlase2026defining,
  title = {{Defining ocular Chlamydia trachomatis infection prevalence thresholds for the trachoma elimination endgame}},
  author = {A. Borlase and J. A. Cohen and E. Kamau and R. Pearson-Clarke and K. K. Renneker and F. T. Akale and P. Akampurira and A. Amza and S. C. Apadinuwe and S. Aragie and S. Araka and Z. Ayele and G. Ayenew and M. S. Bah and R. L. Bailey and A. Bakhtiari and S. Begumisa and T. Bishaw and Y. Y. Bol and L. Boniface and S. Boyd and E. K. Callahan and D. Chaima and B. Chieng and A. Chernet and A. A. Dawed and M. Dejene and D. Duguma and B. E. Elshafie and S. Eshitemi Omukuba and M. Fall and M. F. Shaka and K. Gass and T. Gebre and T. A. Gonzalez and H. Emisiko and E. M. Harding-Esch and P. Hooper and K. A. Jensen and C. Jimenez and B. Kadri and J. M. Kaldor and K. Kalua and H. M. Kanyi},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.02.26366918},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.02.26366918v1},
}
RIS
TY  - UNPB
TI  - Defining ocular Chlamydia trachomatis infection prevalence thresholds for the trachoma elimination endgame
AU  - A. Borlase
AU  - J. A. Cohen
AU  - E. Kamau
AU  - R. Pearson-Clarke
AU  - K. K. Renneker
AU  - F. T. Akale
AU  - P. Akampurira
AU  - A. Amza
AU  - S. C. Apadinuwe
AU  - S. Aragie
AU  - S. Araka
AU  - Z. Ayele
AU  - G. Ayenew
AU  - M. S. Bah
AU  - R. L. Bailey
AU  - A. Bakhtiari
AU  - S. Begumisa
AU  - T. Bishaw
AU  - Y. Y. Bol
AU  - L. Boniface
AU  - S. Boyd
AU  - E. K. Callahan
AU  - D. Chaima
AU  - B. Chieng
AU  - A. Chernet
AU  - A. A. Dawed
AU  - M. Dejene
AU  - D. Duguma
AU  - B. E. Elshafie
AU  - S. Eshitemi Omukuba
AU  - M. Fall
AU  - M. F. Shaka
AU  - K. Gass
AU  - T. Gebre
AU  - T. A. Gonzalez
AU  - H. Emisiko
AU  - E. M. Harding-Esch
AU  - P. Hooper
AU  - K. A. Jensen
AU  - C. Jimenez
AU  - B. Kadri
AU  - J. M. Kaldor
AU  - K. Kalua
AU  - H. M. Kanyi
PY  - 2026
DA  - 2026/11/02
PB  - medRxiv
DO  - 10.64898/2026.11.02.26366918
UR  - https://www.medrxiv.org/content/10.64898/2026.11.02.26366918v1
ER  -